Back
INmune Bio, Inc. 10K Form
Sell
16
INMB
INmune Bio, Inc.
Last Price:
$1.22
Seasonality Move:
2.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INMB News And Ratings
See the #1 stock for the next 7 days that we like better than INMB
INMB Financial Statistics
Sales & Book Value
| Annual Sales: | $50K |
|---|---|
| Cash Flow: | $-5.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.95 |
| Price / Book: | 1.37 |
Profitability
| EPS (TTM): | -2.13980 |
|---|---|
| Net Income (TTM): | $-49.9M |
| Gross Margin: | $-34K |
| Return on Equity: | -161.25% |
| Return on Assets: | -123.98% |
INmune Bio, Inc. Earnings Forecast
Key INmune Bio, Inc. Financial Ratios
-
The Gross Profit Margin over the past 5 years for INMB is -68.00%.
-
The Selling, General & Administrative Expenses for INMB have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 41,318.00% of Revenue.
-
The Net Earning history of INMB is -91,866.00% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 3 years.
INmune Bio, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INMB |
| CUSIP: | 45782T |
| Website: | inmunebio.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 4.17 |
| Quick Ratio: | 3.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INMB Technical Analysis vs Fundamental Analysis
Sell
16
INmune Bio, Inc. (INMB)
is a Sell
Is INmune Bio, Inc. a Buy or a Sell?
-
INmune Bio, Inc. stock is rated a SellThe current INmune Bio, Inc. [INMB] share price is $1.21. The Score for INMB is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.